Future of Reality
an artist collective interested in past, present and future forms of reality

Artist: Virta-Flaneurazine / John Craig Freeman
Title: Virta-Rat
Year: 2007 - present
Project Description: Virta-Rat, the Virta-Flaneurazine clinical trial's resident test subject, played a significant role in the fabled transition from virtual reality to augmented reality. Virta-Rat was first spotted on users cell phones shortly after a powerful new black market version of Virta-Flaneurazine surfaced in the hutongs of central China in the weeks following the Xi'an clinical trials. Known by its street name "Blue Dragon", the drugs unregulated illicit use is thought to be one of the earliest recorded examples of network barrier breach, a troubling phenomenon which is all to common in 2012.
Bio: Virta-Flaneurazine is an artists collective and pharmaceutical start-up, working on the development of a potent programmable mood-changing drug for online virtual worlds and other social networks. Identied as part of the Wanderment family of psychotropic drugs, it causes the user to aimlessly roam the distant lands the Internet. Virta-Flaneurazine was developed to treat Wanderlust Decit Disorder (WDD), or Internet Addiction, an increasingly common disorder characterized by rote repetitive Internet use and the inability of individuals to depart from their daily routines in their physical and virtual lives. As the prograchemistry takes eect, users nd themselves erratically navigating to random Internet locations, behaving strangely, seeing digephemera and walking or ying in circuitous paths. The doctors/artists JC Freeman and WD Pappenheimer have developed a clinical trial program in order to test if Virta-Flaneurazine is eective in treating WDD and to determine if it is safe for human consumption. The clinical trials include an installation and participatory performance in a clinic setting that dispensed and evaluated the drug's effects on volunteer subjects.
Website: http://virtaaneurazine.wordpress.com/
VR Artwork:
AR Model: